These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24581453)

  • 1. Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application.
    Leucht S
    J Clin Psychiatry; 2014; 75 Suppl 1():8-14. PubMed ID: 24581453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking the PANSS, BPRS, and CGI: clinical implications.
    Leucht S; Kane JM; Etschel E; Kissling W; Hamann J; Engel RR
    Neuropsychopharmacology; 2006 Oct; 31(10):2318-25. PubMed ID: 16823384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year functional outcomes of naturalistically treated patients with schizophrenia.
    Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
    Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative remission rates of schizophrenic patients using various remission criteria.
    Beitinger R; Lin J; Kissling W; Leucht S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1643-51. PubMed ID: 18616969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.
    Suzuki T; Uchida H; Sakurai H; Ishizuki T; Tsunoda K; Takeuchi H; Mimura M
    Psychiatry Res; 2015 Jun; 227(2-3):265-9. PubMed ID: 25882098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the concept of remission in schizophrenia.
    Leucht S; Beitinger R; Kissling W
    Psychopharmacology (Berl); 2007 Nov; 194(4):453-61. PubMed ID: 17618422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equipercentile linking of the BPRS and the PANSS.
    Leucht S; Rothe P; Davis JM; Engel RR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptom rating scales and outcome in schizophrenia.
    Mortimer AM
    Br J Psychiatry Suppl; 2007 Aug; 50():s7-14. PubMed ID: 18019038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tools to assess negative symptoms in schizophrenia.
    Kane JM
    J Clin Psychiatry; 2013 Jun; 74(6):e12. PubMed ID: 23842020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.
    Schennach-Wolff R; Meyer S; Seemüller F; Jäger M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ; Riedel M
    J Psychiatr Res; 2011 Dec; 45(12):1639-47. PubMed ID: 21862035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study.
    Helldin L; Kane JM; Hjärthag F; Norlander T
    Schizophr Res; 2009 Nov; 115(1):67-73. PubMed ID: 19666215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS.
    Samara MT; Engel RR; Millier A; Kandenwein J; Toumi M; Leucht S
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1767-72. PubMed ID: 25219937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining treatment-resistant schizophrenia and response to antipsychotics: a review and recommendation.
    Suzuki T; Remington G; Mulsant BH; Uchida H; Rajji TK; Graff-Guerrero A; Mimura M; Mamo DC
    Psychiatry Res; 2012 May; 197(1-2):1-6. PubMed ID: 22429484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remission in schizophrenia: proposed criteria and rationale for consensus.
    Andreasen NC; Carpenter WT; Kane JM; Lasser RA; Marder SR; Weinberger DR
    Am J Psychiatry; 2005 Mar; 162(3):441-9. PubMed ID: 15741458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the early prediction model for symptomatic remission with short-term treatment for schizophrenia.
    Lin CH; Chou LS; Lin CH; Hsu CY; Chen CC; Lane HY
    J Clin Psychopharmacol; 2012 Dec; 32(6):773-7. PubMed ID: 23131876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early improvement in PANSS-30, PANSS-8, and PANSS-6 scores predicts ultimate response and remission during acute treatment of schizophrenia.
    Lin CH; Lin HS; Lin SC; Kuo CC; Wang FC; Huang YH
    Acta Psychiatr Scand; 2018 Feb; 137(2):98-108. PubMed ID: 29280500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of symptom remission in schizophrenia during inpatient treatment.
    Jäger M; Riedel M; Schmauss M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Kühn KU; Lemke MR; Rüther E; Buchkremer G; Gastpar M; Bottlender R; Strauss A; Möller HJ
    World J Biol Psychiatry; 2009; 10(4 Pt 2):426-34. PubMed ID: 17853260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustaining full recovery in schizophrenia after 15 years: does resilience matter?
    Torgalsbøen AK
    Clin Schizophr Relat Psychoses; 2012 Jan; 5(4):193-200. PubMed ID: 22182456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of functional remission in schizophrenic disorder. The FROGS Scale].
    Rouillon F; Baylé FJ; Gorwood P; Lancrenon S; Lançon C; Llorca PM;
    Encephale; 2013 May; 39 Suppl 1():S15-21. PubMed ID: 23541143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remission in schizophrenia: a community-based 6-year follow-up study in Bali.
    Kurihara T; Kato M; Reverger R; Tirta IG
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):476-82. PubMed ID: 21851456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.